Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Jud.Mures – page 3

136 clinical trials in Jud.Mures, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Jud.Mures at a glance
136
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

136 trials in Jud.Mures

Open in trial search

Schizophrenia

Recruiting

A study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:HTL0022537
  • Sponsor:Neurocrine Biosciences Inc.

A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Boehringer Ingelheim International GmbH

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-142
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

Short stature+1

Recruiting

Study of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Endocrinology Division A/S

Evaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Centre Leon Berard

Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Merck Healthcare KGaA

Schizophrenia

Recruiting

A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Brexpiprazole
  • Sponsor:Otsuka Pharmaceutical Co. Ltd.

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Syndax Pharmaceuticals Inc.

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:LTP001
  • Sponsor:Novartis Pharma AG

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Jud.Mures

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on Heart Failure with Reduced Ejection Fraction (HFrEF), investigating novel therapeutic approaches for patients with compromised cardiac function.

  • Treatment Evaluation
  • Safety Assessment
  • Pharmacological Studies

This research aims to enhance treatment options for patients with reduced heart pumping capacity, evaluating both effectiveness and tolerability of new therapeutic interventions over a 12-week period.

02 Therapeutic Development

Advanced clinical investigations in the field of cardiovascular medicine, specifically targeting heart failure management through controlled, randomized studies.

  • Drug Efficacy Testing
  • Patient Safety Monitoring
  • Clinical Outcomes Assessment

The research employs double-blind methodology to ensure reliable evaluation of new therapeutic compounds for heart failure treatment.

03 Clinical Assessments

Multicenter research focusing on cardiac function improvement through systematic evaluation of innovative therapeutic approaches.

  • Treatment Response Analysis
  • Pharmacokinetic Studies
  • Patient Tolerance Assessment

This research initiative aims to expand treatment options for patients with compromised cardiac function through rigorous clinical evaluation.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.